Diabetes Information [Return To Home Page]

Medicinal Properties of Bitter Melon - Good for Diabetics


Bitter Melon is the English name of Momordica charantia, a climbing vine whose leaves and green fruits, although bitter, has been used to fight cancer, diabetes and many infectious diseases. It is also a powerful weapon against HIV/AIDS since some reports claim that bitter melon has substance Q. It is one of the most favorite egetables among the Chinese and the most popular herbal tea as well.

The fruits and leaves of bitter melon are a good source of minerals and vitamins, such as iron, calcium, phosphorus and Vitamin B. However, it is not known how much nutritional contents can actually be absorbed by the body's digestive system of the plant become some of these substances exist in unabsorbable form.

Does Bitter Melon have Medicinal Properties?

Yes. Books and articles about bitter melon states that the extract from the leaves or roots shrinks hemorrhoids. The juice from the leaves is also good to prevent and lessen cough, for fever and against roundworms. Reportedly, it is also used to treat sterility in women and alleviate liver problems. Likewise, bitter melon has some antimicrobial activity and can help infected wounds.

However, none of the medicinal uses of bitter melon has been proven scientifically, although they have not been disproved, either. It's just that it has not been studied enough.

Is it true that bitter melon tea and capsules are effective in lowering blood sugar of diabetics?

There is one case where it is proven that it can lower blood sugar levels from people suffering from Type 2 Diabetes. Results of these scientific studies that determine the effect of drinking of bitter melon extract on blood sugar level of Type 2 Diabetes have consistently shown that bitter melon lowers blood sugar level. The effect on blood sugar is due to momordicin, a substance that is also responsible for it's bitter taste.

The effect of the bitter melon leaves lowering blood sugar level among diabetics is evident regardless of how it is prepared - boiled then eaten, in the form of tea, capsule or tablet. But diabetics should be cautioned about replacing their proprietary medicines with bitter melon teas, capsules or tablets. So far, studies were done only on a very limited number of human subjects so bitter melon and diabetes cannot be labeled conclusive.

In fact, no large clinical trial has yet been published on the preparation of Momordica charantia (bitter melon). The manufacturers of bitter melon teas, capsules and tablets themselves are not claiming healing benefits for their products. They market them only as supplements.

Are they really good substitutes fot the anti-diabetic drugs that are available in the market?

Bitter melon should be considered an addition in the treatment of Type 2 Diabetes Mellitus. It could probably reduce the patients intake of antidiabetic drugs. It should not however, be regarded as a stand-alone medicine.

Also, diabetics who want to try bitter melon need not to spend money on the teas, tablets or capsules. They can cultivate or buy the plant from the market and prepare it themselves.

To prepare bitter melon extract, the following steps should be followed:

  • Wash and finely chop the leaves.
  • Add 6 tablespoons of the chopped leaves in 2 glasses of water.
  • Boil it for 15 min. in an uncovered pot.
  • Cool down and strain.
  • Drink 1/3 cup of it 3x a day.

Alternately, bitter melon tops can be steamed and eaten (1/2 cup 2x a day).

About The Author:
Junji Takano is a Japanese health researcher and has been studying the causes of viruses since 1960s. In 1968, he invented Pyro-Energen, the first electrotherapy device that eradicates viral diseases in a non-narcotic way.
Click here to find out more: http://www.pyroenergen.com
Free newsletter: http://www.pyroenergen.com/newsletter.htm


MORE RESOURCES:


TopNews United States

Novartis drugs fail to prevent diabetes in the overweight
Xinhua
BEIJING, March 15 (Xinhuanet) -- Novartis AG's (NVS) two drugs have failed to prevent diabetes and the problems it causes in the overweight with poor sugar ...
Drugs in pre-diabetics do little to slow progression to diabetes or to heart ...Los Angeles Times (blog)
Search for Better Diabetes Therapy Falls ShortWall Street Journal
Soy products beat drugs for type 2 diabetes prevention?Food Consumer
BusinessWeek -TopNews United States -Visit Bulgaria
all 20 news articles »


FDA wants label information on diabetes injection
MarketWatch
Byuderon is a once-weekly formulation of exenatide, the active ingredient in Byetta which is used in Type 2 diabetes. In the complete response letter, ...
Byetta LARS: How the FDA's Analysis Paralysis May Aid AmylinSeeking Alpha (blog)
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for ...PR Newswire (press release)
FDA finds flaws at Amylin plantCincinnati Business Courier
Financial News USA (press release)
all 18 news articles »


Forbes (blog)

No heart benefit seen with fibrates in diabetics
Reuters
The study run by the National Institutes of Health, dubbed Accord, aimed to see if the dual-drug therapy could reduce cardiovascular events in diabetes ...
Abbott's TriCor Shows No Benefit For Diabetics In StudyWall Street Journal
Abbott's TriCor With Statin Fails to Cut Diabetic Heart RiskBusinessWeek
ACC: FDA Announces Review of ACCORD DataMedPage Today
Forbes (blog) -PR Newswire (press release) -Benzinga
all 69 news articles »


BBC News

No quick drug fix for high diabetes risk
BBC News
Two key treatments do not halt diabetes in people with early signs of the disease, a large study has found. Researchers said the results showed the only way ...
Workplace fruit - helping keep your diet on trackFruitful Office - Office Fruit News Site (blog)

all 7 news articles »


Effect of Valsartan/Nateglinide on the Incidence of Diabetes and ...
Cardiosource
Study Question: Does use of short-acting insulin secretagogues and/or rennin-angiotensin-blockers reduce the risk of diabetes or cardiovascular (CV) events ...
NAVIGATOR: Valsartan slowed progression to diabetes, no effect on CV eventsEndocrine Today
Navigating the Choices for Diabetes PreventionNew England Journal of Medicine (subscription)
NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk ...PR Newswire (press release)
MedPage Today -RTT News
all 22 news articles »


Swiss stocks - Factors to watch on March 15
Reuters
The diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and ...

and more »


Psychologist helps people cope with diabetes
GoErie.com
D., a psychologist who focuses on helping people with diabetes cope with the stress of having the disease. Studies have shown that people with diabetes have ...
Psychologist helps people cope with diabetesGoErie.com

all 2 news articles »


KolkataObserver.com

Aggressive BP control not effective, possibly harmful, in patients with diabetes
Endocrine Today
ATLANTA – Tight systolic blood pressure control in high-risk patients with diabetes appears to be no more effective in avoiding myocardial infarction, ...
Study: 'Ideal' Blood Pressure Level May Be Too Low For DiabeticsAHN | All Headline News
ACC: Pushing Blood Pressure Too Low May be HarmfulMedPage Today
INVEST: Mortality hazard with lowest blood pressures in diabetics with CAD?TheHeart.Org

all 22 news articles »


Lowering BP risky for patients with diabetes, heart disease
Sify
A University of Florida researcher has urged caution in reducing blood pressure in patients with diabetes and coronary disease. ...


Google News






home | site map
© 2006